LOGIN  |  REGISTER
Cue Biopharma

Recent Insider Transactions - Trevi Therapeutics (NASDAQ: TRVI)

Company
Name / Role
Date
Type
Price
# Shares
Value
Balance
NASDAQ TRVI Trevi Therapeutics
Mathers Edward T / director
06/11/2025
Buy
$6.25
45,000
$281K
45,000
NASDAQ TRVI Trevi Therapeutics
Colangelo Dominick / director
06/11/2025
Buy
$6.25
45,000
$281K
45,000
NASDAQ TRVI Trevi Therapeutics
Heffernan Michael Thomas / director
06/11/2025
Buy
$6.25
45,000
$281K
45,000
NASDAQ TRVI Trevi Therapeutics
VANLENT ANNE / director
06/11/2025
Buy
$6.25
45,000
$281K
45,000
NASDAQ TRVI Trevi Therapeutics
Meeker David P / director
06/11/2025
Buy
$6.25
45,000
$281K
45,000